-
-
Qualification
-
R&D Strength
-
Production strength
-
-
Cooperation
-
05
2025
-
11
Great News!!! Several subsidiaries of Xuanyu Pharmaceutical Group have successfully passed the ISO9001 quality system certification and the U.S. FDA certification.
Several subsidiaries of Xuanyu Pharmaceutical Group have successfully passed ISO9001 quality system certification and U.S. FDA certification.
Author:
Xuanyu Pharmaceutical Group, a conglomerate integrating R&D and manufacturing, operates in fields including reproductive medicine, genetic engineering, bioengineering, pharmaceutical and healthcare products, and skincare. Under the leadership of its founder, Mr. Cai Wentao, and after years of relentless efforts, Xuanyu Pharmaceutical Group’s research center has assembled a powerful team of researchers comprising numerous academicians, university professors, clinical medical experts, and dermatologists. In collaboration with the School of Pharmacy at the Central University for Nationalities, the group has established joint R&D laboratories and a research and development center at its Xi'an headquarters—scientific institutions that provide solid technical support for the group’s ongoing innovation and new product development.
Recently, several subsidiaries of our group—Xi'an Xuan Yu Zijin Pharmaceutical, Guizhou Jin Miao Fang Pharmaceutical, and Guizhou Miao Jitang Bio—have successfully passed the ISO 9001 Quality Management System certification and obtained the ISO 9001 Quality Management System Certification Certificate. This milestone signifies that each of our group’s companies has reached a new level in standardization, regularization, and proceduralization of their quality management systems, laying a solid foundation for the company’s long-term and steady development.
In addition, Xian Xuan Yu Zijin Pharmaceutical has also successfully obtained FDA certification from the U.S. Food and Drug Administration. The review process conducted by drug regulatory authorities—particularly the FDA’s rigorous inspections—is renowned for its professionalism, meticulousness, and stringency, representing the highest compliance standards in the global pharmaceutical industry. Faced with this critical test, Xuan Yu Group’s management team and all employees have met the challenge head-on with unwavering conviction, a professional attitude, and an outstanding work ethic. From production to quality control, from documentation systems to on-site operations, every single detail has been rigorously aligned with international standards, and every record has stood up to the most stringent scrutiny. This not only demonstrates our company’s commitment to the core value of “quality first,” but also serves as the best response to the trust placed in Xuan Yu Group by our global partners.
Passing the high-standard certification marks a new starting point for Xuan Yu Group—not an endpoint. We are keenly aware that competition in both domestic and international markets is intensifying, and quality standards and compliance requirements are continually rising. Yet we firmly believe that only by consistently upholding the principle of “quality first” and continuously enhancing our production and R&D capabilities can we lead the industry. Only through relentless innovation and keeping pace with the times can we join forces with more outstanding Chinese enterprises to jointly explore broader overseas markets.
Keywords:
Related News
Xi'an Xuanyu Pharmaceutical Group
Nationwide Unified Customer Service:
Contact phone number:+86 29-89864608
Company email:463879555@qq.com
Address: Room 10402, Unit 1, Building 2, Science and Technology Enterprise Accelerator, No. 6 West Qinling Avenue, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province
Official Account
Mobile site
Copyright © 2026 Xi'an Xuanyu Pharmaceutical Group
SAF Coolest v1.2 设置面板 QVPSF-ZMFA-YSSFE-ZWA
无数据提示
Sorry, there is currently no content in this section.!
You can view other sections or return.Home